NaDeNo (private company)

See something wrong or missing? Let us know
Offices:Trondheim
Business model:B2B

NaDeNo is a biotech startup from Norway developing a nanotechnology drug delivery platform designed for unleashing the potential of hard-to-deliver hydrophobic small molecule drugs.

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to NaDeNo

Name Criteria
Denmark Acesion Pharma
57%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
Denmark AFYX Therapeutics
57%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
United Kingdom Beckley Psytech
57%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
Denmark Biograil
57%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
Germany Biomes
57%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
Germany CatalYm
57%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
Sweden Cinclus Pharma
57%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
Netherlands Citryll
57%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
Finland FinnAdvance
57%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
France InnovaFeed SAS
57%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
Top